US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Pacira Pharmaceuticals

25.18

+1.415.93%

Post-market: 25.180.00000.00%17:46 EDT

Volume:1.25M

Turnover:30.80M

Market Cap:1.13B

PE:-8.97

High:25.23

Open:23.84

Low:23.50

Close:23.77

52wk High:27.64

52wk Low:11.16

Shares:44.93M

Float Shares:44.48M

Volume Ratio:1.06

T/O Rate:2.82%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-2.8063

EPS(LYR):-2.1529

ROE:-15.57%

ROA:2.69%

PB:1.49

PE(LYR):-11.70

Loading ...

Overview Company News Filings

Pacira BioSciences Inc. to Participate in Analyst-Led Fireside Chat at RBC Capital Markets Global Healthcare Conference

Stock Track | Pacira Pharmaceuticals Plummets 7.67% as Q1 Revenue Falls Short of Analyst Expectations

Pacira BioSciences Is Maintained at Buy by Needham

Pacira Q1 Adjusted Earnings Unchanged; Revenue Rises; 2025 Sales Guidance Steady

MT Newswires Live

Stock Track | Pacira Pharmaceuticals Plunges 7.99% as Q1 Revenue Falls Short of Expectations

Stock Track | Pacira Pharmaceuticals Plunges 7.99% After Q1 Revenue Miss Despite Earnings Beat

Pacira Biosciences Inc reports results for the quarter ended March 31 - Earnings Summary

Pacira Biosciences Q1 Adjusted EBITDA USD 44.1 Million Vs. IBES Estimate USD 41.2 Million

Pacira BioSciences Q1 Adj. EPS $0.62 Beats $0.60 Estimate, Sales $168.92M Miss $176.03M Estimate

Pacira BioSciences to Present New Data on Clinical Immunogenicity of Intra-Articular PCRX-201 and Its Implications for Dosing Strategy in Knee Osteoarthritis

Analysts Estimate Pacira (PCRX) to Report a Decline in Earnings: What to Look Out for

Pacira to Report First Quarter 2025 Financial Results on Thursday May 8, 2025

Pacira BioSciences' Gene Therapy Shows Long-Term Improvement in Knee Osteoarthritis Symptoms

MT Newswires Live

Pacira BioSciences Announces Two-Year Efficacy Data Following a Single Local Administration of PCRX-201 in Patients with Mild to Severe Osteoarthritis of the Knee

Pacira BioSciences to Present 104-Week Efficacy Data Following a Single Local Administration of PCRX-201 for Patients with Mild to Severe Osteoarthritis of the Knee

BRIEF-DOMA Perpetual Supports Pacira's New $300 Million Share Repurchase Authorization As A Meaningful Step To Enhance Value For Shareholders

DOMA Perpetual Supports Pacira's New $300 Million Share Repurchase Authorization as a Meaningful Step to Enhance Value for Shareholders

Pacira BioSciences Approves $300 Million Share Repurchase Program

MT Newswires Live

BRIEF-Pacira Biosciences Inc - Authorizes $300 Million Share Repurchase Program

Pacira Biosciences Approves $300M Share Buyback

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/PCRX/news?page=3"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"PCRX","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PCRX\",,,,,undefined,":{"symbol":"PCRX","market":"US","secType":"STK","nameCN":"Pacira Pharmaceuticals","latestPrice":25.18,"timestamp":1754683200000,"preClose":23.77,"halted":0,"volume":1252759,"hourTrading":{"tag":"盘后","latestPrice":25.18,"preClose":25.18,"latestTime":"17:46 EDT","volume":71080,"amount":1789794.4,"timestamp":1754689608210},"delay":0,"floatShares":44476065,"shares":44932721,"eps":-2.806282,"marketStatus":"Market Closed","change":1.41,"latestTime":"08-08 16:00:00 EDT","open":23.84,"high":25.23,"low":23.5,"amount":30803138.954159997,"amplitude":0.072781,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-2.806282,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1754899200000},"marketStatusCode":7,"adr":0,"adrRate":0,"listingDate":1296709200000,"exchange":"NASDAQ","adjPreClose":23.77,"postHourTrading":{"tag":"盘后","latestPrice":25.18,"preClose":25.18,"latestTime":"17:46 EDT","volume":71080,"amount":1789794.4,"timestamp":1754689608210},"volumeRatio":1.0619183948887567,"impliedVol":0.2437,"impliedVolPercentile":0.004},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PCRX\",,,,,undefined,":{"symbol":"PCRX","floatShares":44476065,"roa":"2.69%","roe":"-15.57%","lyrEps":-2.152881,"volumeRatio":1.0619183948887567,"shares":44932721,"dividePrice":0,"high":25.23,"amplitude":0.072781,"preClose":23.77,"low":23.5,"week52Low":11.164,"pbRate":"1.49","psRate":"1.60","week52High":27.64,"institutionHeld":0,"latestPrice":25.18,"eps":-2.806282,"divideRate":0,"volume":1252759,"delay":0,"ttmEps":-2.806282,"open":23.84,"prevYearClose":18.84,"prevWeekClose":22.07,"prevMonthClose":21.09,"prevQuarterClose":23.9,"fiveDayClose":22.07,"twentyDayClose":22.9,"sixtyDayClose":23.4},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/PCRX\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-08-05","symbol":"PCRX","fiscalQuarterEnding":"2025/06","expectedEps":0.49,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1754366400000,"reportTimeType":"post","actualEps":0.47},{"market":"US","date":"2025-05-08","symbol":"PCRX","fiscalQuarterEnding":"2025/03","expectedEps":0.37,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1746676800000,"reportTimeType":"post","actualEps":0.39},{"market":"US","date":"2025-02-27","symbol":"PCRX","fiscalQuarterEnding":"2024/12","expectedEps":0.62,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1740632400000,"reportTimeType":"post","actualEps":0.71},{"market":"US","date":"2025-01-10","symbol":"PCRX","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1736485200000,"reportTimeType":"pre","actualEps":null},{"market":"US","date":"2024-11-06","symbol":"PCRX","fiscalQuarterEnding":"2024/09","expectedEps":0.5,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1730869200000,"reportTimeType":"post","actualEps":0.53}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"PCRX\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"PCRX\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.1429,"buy":0.4286,"hold":0.2857,"sell":0.1429,"strongSell":0,"meanLabel":"BUY","meanPercent":0.4286,"analysts":7,"updateTime":1753502400000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/PCRX\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"PCRX","date":"2025-08-08","current":-8.379498,"percent":0.293496,"low":-401.16991,"twenty":-11.406378,"median":20.026667,"eighty":75.412128,"high":235.945831,"avg":3.450172,"sd":121.719312,"marketCap":1068050778},"quantilePoints":[{"date":"2020-08-14","current":-259.478826,"twenty":-468.628956,"median":-57.355186,"eighty":202.064926,"marketCap":2617103436},{"date":"2020-08-21","current":-258.080361,"twenty":-468.628956,"median":-59.098916,"eighty":202.064926,"marketCap":2602998518},{"date":"2020-08-28","current":-257.656583,"twenty":-468.628956,"median":-59.577554,"eighty":202.064926,"marketCap":2598724300},{"date":"2020-09-04","current":-256.427629,"twenty":-468.628956,"median":-61.447568,"eighty":202.064926,"marketCap":2586329069},{"date":"2020-09-11","current":-244.053333,"twenty":-468.628956,"median":-63.487997,"eighty":202.064926,"marketCap":2461521915},{"date":"2020-09-18","current":-257.52945,"twenty":-468.628956,"median":-63.934618,"eighty":202.064926,"marketCap":2597442035},{"date":"2020-09-25","current":-249.647193,"twenty":-468.628956,"median":-65.131897,"eighty":202.064926,"marketCap":2517941588},{"date":"2020-10-02","current":-252.528878,"twenty":-468.628956,"median":-65.721669,"eighty":202.064926,"marketCap":2547006267},{"date":"2020-10-09","current":-245.663686,"twenty":-468.628956,"median":-66.277721,"eighty":202.064926,"marketCap":2477763942},{"date":"2020-10-16","current":-237.272896,"twenty":-468.628956,"median":-67.459678,"eighty":202.064926,"marketCap":2393134434},{"date":"2020-10-23","current":-235.069255,"twenty":-468.628956,"median":-68.458368,"eighty":202.064926,"marketCap":2370908502},{"date":"2020-10-30","current":17.724515,"twenty":-468.628956,"median":-69.534752,"eighty":202.064926,"marketCap":2235415804},{"date":"2020-11-06","current":17.385058,"twenty":-468.628956,"median":-69.534752,"eighty":202.064926,"marketCap":2192603488},{"date":"2020-11-13","current":21.921638,"twenty":-468.628956,"median":-69.534752,"eighty":202.064926,"marketCap":2764757004},{"date":"2020-11-20","current":22.824132,"twenty":-468.628956,"median":-69.534752,"eighty":202.064926,"marketCap":2878579495},{"date":"2020-11-27","current":21.976752,"twenty":-468.628956,"median":-67.817989,"eighty":202.064926,"marketCap":2771707996},{"date":"2020-12-04","current":20.877915,"twenty":-468.628956,"median":-66.743552,"eighty":202.064926,"marketCap":2633122596},{"date":"2020-12-11","current":20.016757,"twenty":-468.628956,"median":-65.47354,"eighty":202.064926,"marketCap":2524513348},{"date":"2020-12-18","current":20.585121,"twenty":-468.628956,"median":-63.866856,"eighty":202.064926,"marketCap":2596195452},{"date":"2020-12-24","current":20.399111,"twenty":-468.628956,"median":-62.018543,"eighty":202.064926,"marketCap":2572735854},{"date":"2020-12-31","current":20.612678,"twenty":-468.628956,"median":-59.769959,"eighty":202.064926,"marketCap":2599670948},{"date":"2021-01-08","current":24.160649,"twenty":-468.628956,"median":-58.992961,"eighty":202.064926,"marketCap":3047141047},{"date":"2021-01-15","current":25.380049,"twenty":-468.628956,"median":-56.432401,"eighty":202.064926,"marketCap":3200931742},{"date":"2021-01-22","current":23.375273,"twenty":-468.628956,"median":-51.803916,"eighty":202.064926,"marketCap":2948089414},{"date":"2021-01-29","current":22.762128,"twenty":-468.628956,"median":-50.663841,"eighty":202.064926,"marketCap":2870759629},{"date":"2021-02-05","current":25.490277,"twenty":-468.628956,"median":-50.079899,"eighty":202.064926,"marketCap":3214833726},{"date":"2021-02-12","current":26.48922,"twenty":-468.628956,"median":-49.607185,"eighty":202.064926,"marketCap":3340820453},{"date":"2021-02-19","current":26.134423,"twenty":-468.628956,"median":-49.134472,"eighty":202.064926,"marketCap":3296073443},{"date":"2021-02-26","current":21.942318,"twenty":-468.628956,"median":-48.63696,"eighty":202.064926,"marketCap":3193111876},{"date":"2021-03-05","current":20.858228,"twenty":-468.90562,"median":-47.493875,"eighty":202.086827,"marketCap":3035351916},{"date":"2021-03-12","current":22.145289,"twenty":-468.90562,"median":-46.855803,"eighty":202.086827,"marketCap":3222648920},{"date":"2021-03-19","current":21.117449,"twenty":-468.90562,"median":-46.002771,"eighty":202.086827,"marketCap":3073074498},{"date":"2021-03-26","current":21.632876,"twenty":-468.628956,"median":-45.49824,"eighty":202.064926,"marketCap":3148081026},{"date":"2021-04-01","current":21.096349,"twenty":-468.628956,"median":-45.119275,"eighty":202.064926,"marketCap":3070004055},{"date":"2021-04-09","current":20.57188,"twenty":-468.90562,"median":-44.65759,"eighty":202.086827,"marketCap":2993681622},{"date":"2021-04-16","current":19.010527,"twenty":-468.90562,"median":-44.174846,"eighty":202.086827,"marketCap":2766468863},{"date":"2021-04-23","current":19.564509,"twenty":-468.90562,"median":-43.072607,"eighty":202.086827,"marketCap":2847086080},{"date":"2021-04-30","current":19.107833,"twenty":-468.90562,"median":-42.529714,"eighty":202.086827,"marketCap":2780629132},{"date":"2021-05-07","current":18.842844,"twenty":-462.008786,"median":-42.042268,"eighty":202.086827,"marketCap":2783709918},{"date":"2021-05-14","current":18.53901,"twenty":-454.301723,"median":-41.737614,"eighty":202.086827,"marketCap":2738823617},{"date":"2021-05-21","current":19.671437,"twenty":-435.113112,"median":-41.432959,"eighty":202.086827,"marketCap":2906120350},{"date":"2021-05-28","current":18.08008,"twenty":-415.766408,"median":-40.945513,"eighty":202.086827,"marketCap":2671024415},{"date":"2021-06-04","current":18.160542,"twenty":-405.154375,"median":-39.97062,"eighty":202.086827,"marketCap":2682911288},{"date":"2021-06-11","current":18.035379,"twenty":-399.364197,"median":-37.228733,"eighty":202.086827,"marketCap":2664420597},{"date":"2021-06-18","current":17.773133,"twenty":-394.720197,"median":-34.156521,"eighty":202.086827,"marketCap":2625678195},{"date":"2021-06-25","current":18.929399,"twenty":-390.728334,"median":-33.888929,"eighty":202.086827,"marketCap":2796496965},{"date":"2021-07-02","current":17.66585,"twenty":-385.116011,"median":-33.651111,"eighty":202.086827,"marketCap":2609829031},{"date":"2021-07-09","current":16.962554,"twenty":-379.977969,"median":-32.962237,"eighty":202.086827,"marketCap":2505928955},{"date":"2021-07-16","current":16.479783,"twenty":-374.938735,"median":-32.494472,"eighty":202.086827,"marketCap":2434607716},{"date":"2021-07-23","current":17.493006,"twenty":-372.132574,"median":-31.867484,"eighty":202.086827,"marketCap":2584294267},{"date":"2021-07-30","current":17.567508,"twenty":-266.852551,"median":-31.193669,"eighty":202.086827,"marketCap":2595300631},{"date":"2021-08-06","current":15.55933,"twenty":-264.5133,"median":-30.876579,"eighty":201.353121,"marketCap":2708630476},{"date":"2021-08-13","current":14.89283,"twenty":-264.5133,"median":-30.876579,"eighty":200.137577,"marketCap":2592603469},{"date":"2021-08-20","current":14.405085,"twenty":-264.5133,"median":-30.876579,"eighty":195.779142,"marketCap":2507694816},{"date":"2021-08-27","current":15.168623,"twenty":-264.5133,"median":-30.876579,"eighty":187.891968,"marketCap":2640614644},{"date":"2021-09-03","current":14.542982,"twenty":-264.5133,"median":-30.876579,"eighty":182.620157,"marketCap":2531700404},{"date":"2021-09-10","current":14.147167,"twenty":-264.5133,"median":-30.876579,"eighty":179.755465,"marketCap":2462795476},{"date":"2021-09-17","current":14.285064,"twenty":-264.5133,"median":-30.876579,"eighty":176.46703,"marketCap":2486801064},{"date":"2021-09-24","current":14.775363,"twenty":-264.5133,"median":-30.876579,"eighty":173.658928,"marketCap":2572154265},{"date":"2021-10-01","current":14.550642,"twenty":-264.5133,"median":-30.876579,"eighty":172.439621,"marketCap":2533034048},{"date":"2021-10-08","current":12.249813,"twenty":-264.5133,"median":-30.876579,"eighty":170.518288,"marketCap":2132496372},{"date":"2021-10-15","current":13.585366,"twenty":-264.5133,"median":-30.876579,"eighty":169.003391,"marketCap":2364994934},{"date":"2021-10-22","current":13.434702,"twenty":-264.5133,"median":-30.876579,"eighty":167.378747,"marketCap":2338766607},{"date":"2021-10-29","current":13.350432,"twenty":-264.5133,"median":-30.876579,"eighty":161.812377,"marketCap":2324096525},{"date":"2021-11-05","current":41.98928,"twenty":-264.5133,"median":-30.876579,"eighty":160.93735,"marketCap":2587589366},{"date":"2021-11-12","current":41.230307,"twenty":-264.5133,"median":-30.876579,"eighty":160.93735,"marketCap":2540817652},{"date":"2021-11-19","current":40.268941,"twenty":-264.5133,"median":-30.876579,"eighty":160.93735,"marketCap":2481573482},{"date":"2021-11-26","current":37.319789,"twenty":-264.5133,"median":-30.876579,"eighty":160.93735,"marketCap":2299831967},{"date":"2021-12-03","current":37.970337,"twenty":-264.5133,"median":-30.876579,"eighty":160.93735,"marketCap":2339922007},{"date":"2021-12-10","current":41.143567,"twenty":-264.5133,"median":-30.876579,"eighty":160.93735,"marketCap":2535472313},{"date":"2021-12-17","current":41.736289,"twenty":-264.5133,"median":-30.876579,"eighty":160.93735,"marketCap":2571998794},{"date":"2021-12-23","current":44.569788,"twenty":-264.5133,"median":-30.876579,"eighty":160.93735,"marketCap":2746613191},{"date":"2021-12-31","current":43.492769,"twenty":-264.5133,"median":-30.876579,"eighty":160.93735,"marketCap":2680241903},{"date":"2022-01-07","current":43.391573,"twenty":-264.369215,"median":-30.876579,"eighty":160.93735,"marketCap":2674005674},{"date":"2022-01-14","current":46.31904,"twenty":-264.369215,"median":-30.876579,"eighty":160.93735,"marketCap":2854410855},{"date":"2022-01-21","current":45.8492,"twenty":-264.369215,"median":-30.876579,"eighty":160.93735,"marketCap":2825456937},{"date":"2022-01-28","current":44.454135,"twenty":-264.369215,"median":-30.876579,"eighty":160.93735,"marketCap":2739486073},{"date":"2022-02-04","current":46.521433,"twenty":-264.369215,"median":-30.876579,"eighty":160.93735,"marketCap":2866883312},{"date":"2022-02-11","current":46.037136,"twenty":-264.369215,"median":-30.876579,"eighty":160.93735,"marketCap":2837038504},{"date":"2022-02-18","current":46.217844,"twenty":-264.369215,"median":-30.876579,"eighty":159.132789,"marketCap":2848174626},{"date":"2022-02-25","current":71.230861,"twenty":-264.369215,"median":-30.876579,"eighty":46.576368,"marketCap":2990271546},{"date":"2022-03-04","current":76.74852,"twenty":-264.369215,"median":-30.876579,"eighty":46.576368,"marketCap":3221902889},{"date":"2022-03-11","current":75.850135,"twenty":-264.369215,"median":-30.876579,"eighty":46.576368,"marketCap":3184188688},{"date":"2022-03-18","current":77.901294,"twenty":-264.369215,"median":-30.876579,"eighty":46.576368,"marketCap":3270296325},{"date":"2022-03-25","current":81.715167,"twenty":-264.369215,"median":-30.876579,"eighty":46.576368,"marketCap":3430402714},{"date":"2022-04-01","current":83.210804,"twenty":-264.369215,"median":-30.876579,"eighty":46.576368,"marketCap":3493189533},{"date":"2022-04-08","current":87.216973,"twenty":-264.369215,"median":-30.876579,"eighty":46.576368,"marketCap":3661368513},{"date":"2022-04-14","current":79.781523,"twenty":-264.369215,"median":-30.876579,"eighty":46.576368,"marketCap":3349228327},{"date":"2022-04-22","current":79.610593,"twenty":-264.369215,"median":-30.876579,"eighty":46.576368,"marketCap":3342052690},{"date":"2022-04-29","current":79.664008,"twenty":-264.369215,"median":-30.876579,"eighty":46.576368,"marketCap":3344295076},{"date":"2022-05-06","current":74.457218,"twenty":-263.767452,"median":-30.836411,"eighty":68.48052,"marketCap":2862061008},{"date":"2022-05-13","current":72.755069,"twenty":-258.156641,"median":-30.546761,"eighty":71.382776,"marketCap":2796632085},{"date":"2022-05-20","current":75.166447,"twenty":-256.503909,"median":-30.334812,"eighty":74.469039,"marketCap":2889323059},{"date":"2022-05-27","current":76.171188,"twenty":-254.935933,"median":-29.98847,"eighty":74.609976,"marketCap":2927944298},{"date":"2022-06-03","current":76.017522,"twenty":-254.274841,"median":-29.704707,"eighty":75.116801,"marketCap":2922037521},{"date":"2022-06-10","current":65.92283,"twenty":-252.647536,"median":-29.248014,"eighty":75.116801,"marketCap":2534007659},{"date":"2022-06-17","current":63.499631,"twenty":-250.842245,"median":-28.722529,"eighty":75.116801,"marketCap":2440862317},{"date":"2022-06-24","current":67.88503,"twenty":-246.384108,"median":-28.3795,"eighty":75.126258,"marketCap":2609432667},{"date":"2022-07-01","current":68.38149,"twenty":-243.9262,"median":-25.208606,"eighty":75.126258,"marketCap":2628516103},{"date":"2022-07-08","current":67.341288,"twenty":-241.866642,"median":-24.217702,"eighty":75.126258,"marketCap":2588531761},{"date":"2022-07-15","current":65.012653,"twenty":-229.797465,"median":12.415799,"eighty":75.126258,"marketCap":2499021360},{"date":"2022-07-22","current":65.225421,"twenty":-203.209913,"median":13.281483,"eighty":75.126258,"marketCap":2507199975},{"date":"2022-07-29","current":66.856648,"twenty":-184.560092,"median":13.411719,"eighty":75.126258,"marketCap":2569902693},{"date":"2022-08-05","current":68.200294,"twenty":-180.744559,"median":13.564937,"eighty":75.126258,"marketCap":2675770325},{"date":"2022-08-12","current":67.228463,"twenty":-180.744559,"median":13.953091,"eighty":75.126258,"marketCap":2637641527},{"date":"2022-08-19","current":68.046044,"twenty":-180.744559,"median":14.147167,"eighty":75.126258,"marketCap":2669718474},{"date":"2022-08-26","current":63.140562,"twenty":-180.744559,"median":14.341244,"eighty":75.126258,"marketCap":2477256792},{"date":"2022-09-02","current":60.384148,"twenty":-180.744559,"median":14.507231,"eighty":75.126258,"marketCap":2369111657},{"date":"2022-09-09","current":65.114434,"twenty":-180.744559,"median":14.55575,"eighty":75.126258,"marketCap":2554699707},{"date":"2022-09-16","current":62.603294,"twenty":-180.744559,"median":14.729397,"eighty":75.126258,"marketCap":2456177656},{"date":"2022-09-23","current":61.738995,"twenty":-180.744559,"median":14.928581,"eighty":75.126258,"marketCap":2422267740},{"date":"2022-09-30","current":62.124426,"twenty":-180.744559,"median":15.130319,"eighty":75.126258,"marketCap":2437389729},{"date":"2022-10-07","current":65.768498,"twenty":-180.744559,"median":15.459738,"eighty":75.126258,"marketCap":2580361265},{"date":"2022-10-14","current":60.267351,"twenty":-180.744559,"median":16.530444,"eighty":75.126258,"marketCap":2364529236},{"date":"2022-10-21","current":60.372468,"twenty":-180.744559,"median":16.846331,"eighty":75.126258,"marketCap":2368653414},{"date":"2022-10-28","current":61.026532,"twenty":-180.744559,"median":17.305262,"eighty":75.126258,"marketCap":2394314972},{"date":"2022-11-04","current":109.558015,"twenty":-180.744559,"median":17.567508,"eighty":75.23908,"marketCap":2287680907},{"date":"2022-11-11","current":116.303765,"twenty":-180.744559,"median":17.724515,"eighty":75.912385,"marketCap":2428538917},{"date":"2022-11-18","current":107.756218,"twenty":-180.744559,"median":17.883395,"eighty":76.245411,"marketCap":2250057595},{"date":"2022-11-25","current":109.184472,"twenty":-180.744559,"median":18.014518,"eighty":77.33224,"marketCap":2279880952},{"date":"2022-12-02","current":103.823028,"twenty":-180.744559,"median":18.09498,"eighty":78.573062,"marketCap":2167928658},{"date":"2022-12-09","current":100.746791,"twenty":-180.744559,"median":18.160542,"eighty":79.43539,"marketCap":2103693734},{"date":"2022-12-16","current":84.464703,"twenty":-180.744559,"median":18.258884,"eighty":80.020825,"marketCap":1763707462},{"date":"2022-12-23","current":87.167398,"twenty":-180.744559,"median":18.360206,"eighty":80.846851,"marketCap":1820142430},{"date":"2022-12-30","current":84.838246,"twenty":-180.744559,"median":18.464509,"eighty":81.37117,"marketCap":1771507417},{"date":"2023-01-06","current":81.476358,"twenty":-180.744559,"median":18.53901,"eighty":81.644659,"marketCap":1701307823},{"date":"2023-01-13","current":82.223444,"twenty":-180.744559,"median":18.842844,"eighty":82.157524,"marketCap":1716907732},{"date":"2023-01-20","current":78.070523,"twenty":-180.744559,"median":19.010527,"eighty":82.532655,"marketCap":1630190586},{"date":"2023-01-27","current":86.574123,"twenty":-180.744559,"median":19.416316,"eighty":83.555016,"marketCap":1807754267},{"date":"2023-02-03","current":91.979513,"twenty":-180.744559,"median":19.564509,"eighty":84.517439,"marketCap":1920624203},{"date":"2023-02-10","current":87.782645,"twenty":-180.744559,"median":19.787659,"eighty":85.348023,"marketCap":1832989415},{"date":"2023-02-17","current":92.067405,"twenty":-180.744559,"median":20.109762,"eighty":86.402733,"marketCap":1922459487},{"date":"2023-02-24","current":90.089824,"twenty":-180.744559,"median":20.261417,"eighty":87.249878,"marketCap":1881165608},{"date":"2023-03-03","current":121.459584,"twenty":-180.744559,"median":20.375957,"eighty":88.468207,"marketCap":1932300522},{"date":"2023-03-10","current":115.682672,"twenty":-180.744559,"median":20.481454,"eighty":89.566863,"marketCap":1840395622},{"date":"2023-03-17","current":114.065136,"twenty":-180.744559,"median":20.612678,"eighty":90.48534,"marketCap":1814662250},{"date":"2023-03-24","current":113.054176,"twenty":-180.744559,"median":20.764788,"eighty":92.084983,"marketCap":1798578893},{"date":"2023-03-31","current":117.877898,"twenty":-180.634035,"median":20.864626,"eighty":100.131543,"marketCap":1875319484},{"date":"2023-04-06","current":118.108975,"twenty":-180.634035,"median":20.939611,"eighty":103.2737,"marketCap":1878995680},{"date":"2023-04-14","current":121.863968,"twenty":-180.744559,"median":21.098371,"eighty":105.035945,"marketCap":1938733865},{"date":"2023-04-21","current":134.342099,"twenty":-180.744559,"median":21.271173,"eighty":107.527698,"marketCap":2137248449},{"date":"2023-04-28","current":129.200647,"twenty":-180.744559,"median":21.509294,"eighty":109.333889,"marketCap":2055453088},{"date":"2023-05-05","current":-189.762404,"twenty":-185.939215,"median":21.533408,"eighty":110.155684,"marketCap":1983965934},{"date":"2023-05-12","current":-184.835796,"twenty":-188.662715,"median":21.533408,"eighty":110.155684,"marketCap":1932458242},{"date":"2023-05-19","current":-177.225945,"twenty":-188.662715,"median":21.533408,"eighty":110.155684,"marketCap":1852897253},{"date":"2023-05-26","current":-174.806628,"twenty":-188.662715,"median":21.533408,"eighty":110.155684,"marketCap":1827603297},{"date":"2023-06-02","current":-167.32874,"twenty":-188.662715,"median":21.533408,"eighty":110.155684,"marketCap":1749421978},{"date":"2023-06-09","current":-162.79802,"twenty":-188.662715,"median":21.533408,"eighty":110.155684,"marketCap":1702053297},{"date":"2023-06-16","current":-177.357908,"twenty":-188.662715,"median":21.533408,"eighty":110.155684,"marketCap":1854276923},{"date":"2023-06-23","current":-173.618964,"twenty":-188.662715,"median":21.542451,"eighty":110.300707,"marketCap":1815186264},{"date":"2023-06-30","current":-173.794914,"twenty":-188.662715,"median":21.551493,"eighty":110.445729,"marketCap":1817025824},{"date":"2023-07-07","current":-168.560392,"twenty":-188.662715,"median":21.551493,"eighty":110.445729,"marketCap":1762298901},{"date":"2023-07-14","current":-163.897709,"twenty":-188.662715,"median":21.551493,"eighty":110.445729,"marketCap":1713550549},{"date":"2023-07-21","current":-166.405001,"twenty":-188.662715,"median":21.551493,"eighty":110.445729,"marketCap":1739764286},{"date":"2023-07-28","current":-158.927113,"twenty":-188.662715,"median":21.551493,"eighty":110.445729,"marketCap":1661582967},{"date":"2023-08-04","current":-393.752127,"twenty":-189.51606,"median":21.551493,"eighty":110.445729,"marketCap":1798659718},{"date":"2023-08-11","current":-384.302076,"twenty":-222.796665,"median":21.551493,"eighty":110.445729,"marketCap":1755491885},{"date":"2023-08-18","current":-371.193941,"twenty":-231.373916,"median":21.551493,"eighty":110.445729,"marketCap":1695613923},{"date":"2023-08-25","current":-378.103656,"twenty":-242.611981,"median":21.551493,"eighty":110.445729,"marketCap":1727177500},{"date":"2023-09-01","current":-358.695486,"twenty":-245.663686,"median":21.592185,"eighty":110.590752,"marketCap":1638520982},{"date":"2023-09-08","current":-347.518007,"twenty":-246.511241,"median":21.592185,"eighty":110.590752,"marketCap":1587462255},{"date":"2023-09-15","current":-353.309974,"twenty":-250.876147,"median":21.592185,"eighty":110.590752,"marketCap":1613919959},{"date":"2023-09-22","current":-341.827653,"twenty":-253.122167,"median":21.592185,"eighty":110.590752,"marketCap":1561468721},{"date":"2023-09-29","current":-313.4775,"twenty":-254.308743,"median":21.592185,"eighty":110.590752,"marketCap":1431965221},{"date":"2023-10-06","current":-295.288692,"twenty":-255.580075,"median":21.592185,"eighty":110.590752,"marketCap":1348878746},{"date":"2023-10-13","current":-298.74355,"twenty":-257.148051,"median":21.592185,"eighty":110.590752,"marketCap":1364660535},{"date":"2023-10-20","current":-291.528995,"twenty":-259.436448,"median":21.592185,"eighty":110.590752,"marketCap":1331704447},{"date":"2023-10-27","current":-277.303111,"twenty":-262.657155,"median":21.661695,"eighty":110.669855,"marketCap":1266720612},{"date":"2023-11-03","current":194.03021,"twenty":-263.784403,"median":21.825188,"eighty":111.49441,"marketCap":1354912959},{"date":"2023-11-10","current":189.06257,"twenty":-258.3092,"median":22.003622,"eighty":113.654975,"marketCap":1320223924},{"date":"2023-11-17","current":185.870518,"twenty":-256.656469,"median":22.225926,"eighty":115.033075,"marketCap":1297933826},{"date":"2023-11-24","current":178.954406,"twenty":-255.580075,"median":22.762128,"eighty":115.931079,"marketCap":1249638614},{"date":"2023-12-01","current":181.414946,"twenty":-254.291792,"median":23.626731,"eighty":117.831683,"marketCap":1266820565},{"date":"2023-12-08","current":185.804017,"twenty":-253.189971,"median":24.074533,"eighty":119.426111,"marketCap":1297469449},{"date":"2023-12-15","current":204.756825,"twenty":-250.893098,"median":24.918468,"eighty":120.956992,"marketCap":1429816906},{"date":"2023-12-22","current":219.25406,"twenty":-246.595997,"median":25.464442,"eighty":122.678301,"marketCap":1531051100},{"date":"2023-12-29","current":223.310626,"twenty":-245.841673,"median":25.631507,"eighty":125.380464,"marketCap":1559378100},{"date":"2024-01-05","current":215.596501,"twenty":-243.495181,"median":26.14648,"eighty":128.992678,"marketCap":1505510363},{"date":"2024-01-12","current":217.126025,"twenty":-234.391211,"median":26.866408,"eighty":134.550068,"marketCap":1516191035},{"date":"2024-01-19","current":211.007926,"twenty":-224.474823,"median":37.970337,"eighty":178.954406,"marketCap":1473468347},{"date":"2024-01-26","current":215.396997,"twenty":-189.714651,"median":39.159395,"eighty":183.143974,"marketCap":1504117232},{"date":"2024-02-02","current":211.307181,"twenty":-187.413467,"median":40.561688,"eighty":185.737516,"marketCap":1475558044},{"date":"2024-02-09","current":184.207991,"twenty":-183.479123,"median":40.764081,"eighty":186.987736,"marketCap":1286324400},{"date":"2024-02-16","current":197.242202,"twenty":-180.007976,"median":41.183323,"eighty":189.461576,"marketCap":1377342300},{"date":"2024-02-23","current":199.303736,"twenty":-177.815378,"median":41.674848,"eighty":191.270406,"marketCap":1391737988},{"date":"2024-03-01","current":32.895449,"twenty":-176.49104,"median":41.98928,"eighty":194.161876,"marketCap":1380128562},{"date":"2024-03-08","current":33.95981,"twenty":-174.595488,"median":41.98928,"eighty":194.161876,"marketCap":1424783837},{"date":"2024-03-15","current":32.430289,"twenty":-172.512246,"median":41.98928,"eighty":194.161876,"marketCap":1360612764},{"date":"2024-03-22","current":32.463539,"twenty":-170.073565,"median":41.98928,"eighty":194.161876,"marketCap":1362007787},{"date":"2024-03-28","current":32.186452,"twenty":-167.038422,"median":41.98928,"eighty":194.161876,"marketCap":1350382593},{"date":"2024-04-05","current":31.477109,"twenty":-165.270122,"median":42.151917,"eighty":194.205765,"marketCap":1320622095},{"date":"2024-04-12","current":30.324426,"twenty":-163.478558,"median":42.151917,"eighty":194.205765,"marketCap":1272261286},{"date":"2024-04-19","current":28.927906,"twenty":-162.015041,"median":42.151917,"eighty":194.205765,"marketCap":1213670305},{"date":"2024-04-26","current":28.276516,"twenty":-160.106357,"median":41.98928,"eighty":194.161876,"marketCap":1186341217},{"date":"2024-05-03","current":30.294683,"twenty":-159.243824,"median":41.750745,"eighty":193.772182,"marketCap":1271013414},{"date":"2024-05-10","current":19.722832,"twenty":-159.243824,"median":41.223078,"eighty":189.740881,"marketCap":1389867979},{"date":"2024-05-17","current":20.812674,"twenty":-159.243824,"median":40.839978,"eighty":187.708847,"marketCap":1466669123},{"date":"2024-05-24","current":20.026667,"twenty":-159.243824,"median":40.652042,"eighty":185.671015,"marketCap":1411279207},{"date":"2024-05-31","current":20.119138,"twenty":-159.243824,"median":39.293118,"eighty":183.981888,"marketCap":1417795668},{"date":"2024-06-07","current":19.234055,"twenty":-159.243824,"median":38.035392,"eighty":179.393313,"marketCap":1355423829},{"date":"2024-06-14","current":18.738672,"twenty":-159.349394,"median":34.597111,"eighty":136.681748,"marketCap":1320514218},{"date":"2024-06-21","current":18.494283,"twenty":-159.454964,"median":33.372385,"eighty":130.875951,"marketCap":1303292144},{"date":"2024-06-28","current":18.434837,"twenty":-159.53117,"median":32.779246,"eighty":125.380464,"marketCap":1299102990},{"date":"2024-07-05","current":14.306649,"twenty":-159.53117,"median":32.463539,"eighty":122.320681,"marketCap":1008189565},{"date":"2024-07-12","current":14.405726,"twenty":-159.53117,"median":32.336079,"eighty":120.645039,"marketCap":1015171487},{"date":"2024-07-15","current":14.3727,"twenty":-159.53117,"median":32.247411,"eighty":120.263763,"marketCap":1012844180},{"date":"2024-08-02","current":15.050935,"twenty":-160.05395,"median":31.565777,"eighty":116.312415,"marketCap":957134129},{"date":"2024-08-09","current":16.218743,"twenty":-160.05395,"median":30.294683,"eighty":115.167009,"marketCap":1031398512},{"date":"2024-08-16","current":9.683373,"twenty":-160.05395,"median":29.729152,"eighty":113.764737,"marketCap":615794729},{"date":"2024-08-23","current":10.133088,"twenty":-160.05395,"median":29.108178,"eighty":111.616908,"marketCap":644393435},{"date":"2024-08-30","current":11.141319,"twenty":-160.05395,"median":28.720069,"eighty":109.61954,"marketCap":708509890},{"date":"2024-09-06","current":10.648083,"twenty":-160.05395,"median":26.623561,"eighty":107.685904,"marketCap":677143567},{"date":"2024-09-13","current":9.233658,"twenty":-160.05395,"median":26.134423,"eighty":106.02913,"marketCap":587196022},{"date":"2024-09-20","current":10.655337,"twenty":-160.05395,"median":25.572948,"eighty":103.787871,"marketCap":677604836},{"date":"2024-09-27","current":10.394212,"twenty":-160.05395,"median":25.262931,"eighty":101.124729,"marketCap":660999136},{"date":"2024-10-04","current":11.525752,"twenty":-160.05395,"median":24.160649,"eighty":92.278347,"marketCap":732957171},{"date":"2024-10-11","current":11.250121,"twenty":-160.05395,"median":23.726625,"eighty":90.775385,"marketCap":715428932},{"date":"2024-10-18","current":12.294619,"twenty":-160.05395,"median":22.824132,"eighty":89.650361,"marketCap":781851734},{"date":"2024-10-25","current":12.345394,"twenty":-160.05395,"median":22.225926,"eighty":89.048298,"marketCap":785080620},{"date":"2024-10-31","current":12.236592,"twenty":-160.05395,"median":22.018088,"eighty":87.554125,"marketCap":778161579},{"date":"2024-11-08","current":-9.007576,"twenty":-160.080154,"median":21.834529,"eighty":86.402733,"marketCap":817266348},{"date":"2024-11-15","current":-8.330735,"twenty":-160.080154,"median":21.542451,"eighty":85.348023,"marketCap":755855938},{"date":"2024-11-22","current":-8.844727,"twenty":-160.080154,"median":21.332964,"eighty":84.517439,"marketCap":802490911},{"date":"2024-11-29","current":-8.605543,"twenty":-160.080154,"median":21.153619,"eighty":83.849455,"marketCap":780789488},{"date":"2024-12-06","current":-9.501211,"twenty":-160.080154,"median":21.095638,"eighty":82.532655,"marketCap":862054390},{"date":"2024-12-13","current":-10.076271,"twenty":-160.080154,"median":20.915498,"eighty":81.766446,"marketCap":914230152},{"date":"2024-12-20","current":-9.959223,"twenty":-160.080154,"median":20.826245,"eighty":81.394569,"marketCap":903610306},{"date":"2024-12-27","current":-10.08136,"twenty":-160.080154,"median":20.755904,"eighty":81.057087,"marketCap":914691884},{"date":"2025-01-03","current":-9.328184,"twenty":-160.080154,"median":20.621289,"eighty":80.800692,"marketCap":846355489},{"date":"2025-01-10","current":-9.45541,"twenty":-160.106357,"median":20.50245,"eighty":79.734517,"marketCap":857898799},{"date":"2025-01-17","current":-11.226391,"twenty":-160.106357,"median":20.403158,"eighty":79.367018,"marketCap":1018581674},{"date":"2025-01-24","current":-11.872697,"twenty":-160.106357,"median":20.356922,"eighty":78.663234,"marketCap":1077221689},{"date":"2025-01-31","current":-13.353604,"twenty":-160.106357,"median":20.288883,"eighty":77.781643,"marketCap":1211585817},{"date":"2025-02-07","current":-13.363782,"twenty":-160.106357,"median":20.213101,"eighty":76.245411,"marketCap":1212509282},{"date":"2025-02-14","current":-13.501185,"twenty":-160.106357,"median":20.066297,"eighty":75.943509,"marketCap":1224976057},{"date":"2025-02-21","current":-13.099152,"twenty":-159.974584,"median":20.016757,"eighty":75.406422,"marketCap":1188499197},{"date":"2025-02-28","current":-11.770559,"twenty":-158.909518,"median":20.016757,"eighty":75.406422,"marketCap":1171876831},{"date":"2025-03-07","current":-11.090308,"twenty":-157.685648,"median":20.021712,"eighty":75.409275,"marketCap":1104151110},{"date":"2025-03-14","current":-10.546484,"twenty":-157.685648,"median":20.021712,"eighty":75.409275,"marketCap":1050007908},{"date":"2025-03-21","current":-11.071716,"twenty":-157.685648,"median":20.021712,"eighty":75.409275,"marketCap":1102300060},{"date":"2025-03-28","current":-11.759631,"twenty":-157.685648,"median":20.021712,"eighty":75.409275,"marketCap":1170788897},{"date":"2025-04-04","current":-11.290176,"twenty":-157.685648,"median":20.021712,"eighty":75.409275,"marketCap":1124049893},{"date":"2025-04-11","current":-11.011291,"twenty":-157.662708,"median":20.016757,"eighty":75.406422,"marketCap":1096284149},{"date":"2025-04-17","current":-11.373841,"twenty":-157.662708,"median":20.016757,"eighty":75.406422,"marketCap":1132379617},{"date":"2025-04-25","current":-12.084997,"twenty":-157.685648,"median":20.021712,"eighty":75.409275,"marketCap":1203182266},{"date":"2025-05-02","current":-12.433602,"twenty":-127.013477,"median":20.021712,"eighty":75.409275,"marketCap":1237889446},{"date":"2025-05-09","current":-11.116725,"twenty":-13.492025,"median":20.021712,"eighty":75.409275,"marketCap":1153104575},{"date":"2025-05-16","current":-11.428071,"twenty":-13.282357,"median":20.021712,"eighty":75.409275,"marketCap":1185399475},{"date":"2025-05-23","current":-11.637883,"twenty":-13.103223,"median":20.021712,"eighty":75.409275,"marketCap":1207162668},{"date":"2025-05-30","current":-11.575386,"twenty":-12.927144,"median":20.021712,"eighty":75.409275,"marketCap":1200680015},{"date":"2025-06-06","current":-11.936977,"twenty":-12.540508,"median":20.021712,"eighty":75.409275,"marketCap":1238186795},{"date":"2025-06-13","current":-10.9147,"twenty":-12.185395,"median":20.021712,"eighty":75.409275,"marketCap":1132149108},{"date":"2025-06-20","current":-10.780778,"twenty":-11.996683,"median":20.026667,"eighty":75.412128,"marketCap":1118257708},{"date":"2025-06-27","current":-10.584358,"twenty":-11.829352,"median":20.026667,"eighty":75.412128,"marketCap":1097883654},{"date":"2025-07-03","current":-10.365617,"twenty":-11.713772,"median":20.026667,"eighty":75.412128,"marketCap":1075194367},{"date":"2025-07-11","current":-10.575429,"twenty":-11.669131,"median":20.026667,"eighty":75.412128,"marketCap":1096957561},{"date":"2025-07-18","current":-9.950457,"twenty":-11.578356,"median":20.026667,"eighty":75.412128,"marketCap":1032131027},{"date":"2025-07-25","current":-9.740645,"twenty":-11.54582,"median":20.026667,"eighty":75.412128,"marketCap":1010367833},{"date":"2025-08-01","current":-9.414766,"twenty":-11.457506,"median":20.026667,"eighty":75.412128,"marketCap":976565427},{"date":"2025-08-08","current":-8.379498,"twenty":-11.406378,"median":20.026667,"eighty":75.412128,"marketCap":1068050778}],"updateTime":1754745013292},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"PCRX\",pageSize:20,pageCount:3,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2535025427","title":"Pacira BioSciences Inc. to Participate in Analyst-Led Fireside Chat at RBC Capital Markets Global Healthcare Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2535025427","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535025427?lang=en_us&edition=fundamental","pubTime":"2025-05-14 20:00","pubTimestamp":1747224046,"startTime":"0","endTime":"0","summary":"Pacira BioSciences, Inc. , a leader in non-opioid pain therapies, is set to participate in a fireside chat at the 2025 RBC Capital Markets Global Healthcare Conference on May 21st at 8:30AM ET. The company will engage in an analyst-led discussion during the event.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Pacira Biosciences Inc. published the original content used to generate this news brief via GlobeNewswire  on May 14, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250514:nNDL55sm2P:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2210149790.SGD","PCRX","IE00B64PRP62.GBP","IE00B3QW5Z07.USD","BK4588","BK4585","LU2095319765.USD","LU2210150020.SGD","NDAQ","BK4112","IE00BGHQF748.EUR","BK4007","IE00BKPKM429.USD"],"gpt_icon":0},{"id":"1141104565","title":"Stock Track | Pacira Pharmaceuticals Plummets 7.67% as Q1 Revenue Falls Short of Analyst Expectations","url":"https://stock-news.laohu8.com/highlight/detail?id=1141104565","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1141104565?lang=en_us&edition=fundamental","pubTime":"2025-05-09 21:34","pubTimestamp":1746797697,"startTime":"0","endTime":"0","summary":"Pacira Pharmaceuticals  experienced a significant downturn in pre-market trading, with its stock plummeting 7.67% following the release of its first-quarter 2025 financial results. Despite beating earnings estimates, the company's revenue fell short of expectations, disappointing investors and triggering a sell-off.The biopharmaceutical company reported Q1 revenue of $168.92 million, missing the analyst consensus estimate of $176.03 million by 4.03%. This represents a modest 1.08% increase from ","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["PCRX"],"gpt_icon":0},{"id":"2534248483","title":"Pacira BioSciences Is Maintained at Buy by Needham","url":"https://stock-news.laohu8.com/highlight/detail?id=2534248483","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2534248483?lang=en_us&edition=fundamental","pubTime":"2025-05-09 20:58","pubTimestamp":1746795480,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/PCRX/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  May 09, 2025 08:58 ET (12:58 GMT)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PCRX"],"gpt_icon":0},{"id":"2534275241","title":"Pacira Q1 Adjusted Earnings Unchanged; Revenue Rises; 2025 Sales Guidance Steady","url":"https://stock-news.laohu8.com/highlight/detail?id=2534275241","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2534275241?lang=en_us&edition=fundamental","pubTime":"2025-05-09 16:13","pubTimestamp":1746778424,"startTime":"0","endTime":"0","summary":"Pacira Biosciences  reported Q1 non-GAAP earnings late Thursday of $0.62 per diluted share, unchanged from a year earlier.Analysts polled by FactSet expected $0.60.Revenue for the quarter ended March 31 was $168.9 million compared with $167.1 million a year earlier.Analysts surveyed by FactSet expected $176 million.The company reiterated its 2025 revenue guidance of $725 million to $765 million. Analysts surveyed by FactSet expect $749.9 million.Pacira shares were down 7.6% in recent premarket activity Friday.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["PCRX"],"gpt_icon":0},{"id":"1174688883","title":"Stock Track | Pacira Pharmaceuticals Plunges 7.99% as Q1 Revenue Falls Short of Expectations","url":"https://stock-news.laohu8.com/highlight/detail?id=1174688883","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1174688883?lang=en_us&edition=fundamental","pubTime":"2025-05-09 14:41","pubTimestamp":1746772860,"startTime":"0","endTime":"0","summary":"Pacira Pharmaceuticals  saw its stock plummet 7.99% in Friday's trading session following the release of its first-quarter 2025 financial results. Despite beating earnings estimates, the company's revenue fell short of analyst expectations, raising concerns about its growth trajectory.The biopharmaceutical company reported Q1 revenue of $168.92 million, missing the analyst consensus estimate of $176.03 million by 4.03%. This represents a modest 1.08% increase from the same period last year. The ","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["PCRX"],"gpt_icon":0},{"id":"1147452468","title":"Stock Track | Pacira Pharmaceuticals Plunges 7.99% After Q1 Revenue Miss Despite Earnings Beat","url":"https://stock-news.laohu8.com/highlight/detail?id=1147452468","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1147452468?lang=en_us&edition=fundamental","pubTime":"2025-05-09 14:40","pubTimestamp":1746772844,"startTime":"0","endTime":"0","summary":"Pacira Pharmaceuticals  saw its stock plummet 7.99% in Friday's trading session following the release of its first-quarter 2025 financial results. Despite beating earnings estimates, the company's revenue fell short of expectations, disappointing investors and triggering a sell-off.The biopharmaceutical company reported adjusted earnings per share of $0.62, surpassing the analyst consensus estimate of $0.60. This represents a 3.33% beat and matches the company's performance from the same period ","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Stock Track | Pacira Pharmaceuticals Plunges 7.99% After Q1 Revenue Miss Despite Earnings Beat","news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["PCRX"],"gpt_icon":0},{"id":"2534162792","title":"Pacira Biosciences Inc reports results for the quarter ended March 31 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2534162792","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2534162792?lang=en_us&edition=fundamental","pubTime":"2025-05-09 05:01","pubTimestamp":1746738077,"startTime":"0","endTime":"0","summary":"Pacira Biosciences Inc reports results for the quarter ended March 31 - Earnings SummaryPacira Biosciences Inc PCRX.OQ reported quarterly adjusted earnings of 62 cents per share for the quarter ended ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250508:nL8N3RG3IJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PCRX"],"gpt_icon":0},{"id":"2534116908","title":"Pacira Biosciences Q1 Adjusted EBITDA USD 44.1 Million Vs. IBES Estimate USD 41.2 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2534116908","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2534116908?lang=en_us&edition=fundamental","pubTime":"2025-05-09 04:11","pubTimestamp":1746735089,"startTime":"0","endTime":"0","summary":"May 08 (Reuters) - Pacira Biosciences Q1 cash & investments USD 493.6 million.:  ((Reuters Investor Briefs; email: reutersinvestor.briefs@thomsonreuters.com))  Source Date/Time = 08-MAY-202520:00:45.863 GMT","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250508:nRSD18gQnt:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","PCRX"],"gpt_icon":0},{"id":"2534165067","title":"Pacira BioSciences Q1 Adj. EPS $0.62 Beats $0.60 Estimate, Sales $168.92M Miss $176.03M Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2534165067","media":"Benzinga","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2534165067?lang=en_us&edition=fundamental","pubTime":"2025-05-09 04:01","pubTimestamp":1746734473,"startTime":"0","endTime":"0","summary":"Pacira BioSciences (NASDAQ:PCRX) reported quarterly earnings of $0.62 per share which beat the analyst consensus estimate of $0.60 by 3.33 percent. This is unchanged from the same period last year.  The company reported","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/25/05/45298986/pacira-biosciences-q1-adj-eps-0-62-beats-0-60-estimate-sales-168-92m-miss-176-03m-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PCRX"],"gpt_icon":0},{"id":"2532848245","title":"Pacira BioSciences to Present New Data on Clinical Immunogenicity of Intra-Articular PCRX-201 and Its Implications for Dosing Strategy in Knee Osteoarthritis","url":"https://stock-news.laohu8.com/highlight/detail?id=2532848245","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2532848245?lang=en_us&edition=fundamental","pubTime":"2025-05-02 20:00","pubTimestamp":1746187200,"startTime":"0","endTime":"0","summary":"Data will be featured at the ASGCT 28th Annual Meeting. BRISBANE, Calif., May 02, 2025  -- Pacira BioSciences, Inc. , the industry leader in its commitment to deliver innovative, non-opioid pain therapies to transform the lives of patients, today announced an upcoming podium presentation of findings from its Phase 1 study of PCRX-201 , a locally administered gene therapy candidate for osteoarthritis of the knee. The data will be presented at the 28th Annual Meeting of the American Society of Gene and Cell Therapy  in New Orleans on May 15. The presentation will highlight how preexisting and treatment-induced neutralizing antibodies  impact the therapy’s efficacy, safety, and redosing potential.Presentation Title: Understanding the Clinical Immunogenicity of Locally Injected HCAd Vector Provides Insight into Optimizing Dosing Strategy. Date and Time: Thursday, May 15 from 2:15–2:30 PM CT, during the “Immunogenicity/NAb Titers” oral session at ASGCT 2025. Given the promising Phase 1 resu","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/pacira-biosciences-present-data-clinical-120000290.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4007","ATMP","PCRX"],"gpt_icon":1},{"id":"2531275088","title":"Analysts Estimate Pacira (PCRX) to Report a Decline in Earnings: What to Look Out for","url":"https://stock-news.laohu8.com/highlight/detail?id=2531275088","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531275088?lang=en_us&edition=fundamental","pubTime":"2025-04-29 22:01","pubTimestamp":1745935290,"startTime":"0","endTime":"0","summary":"Pacira  is expected to deliver a year-over-year decline in earnings on higher revenues when it reports results for the quarter ended March 2025. This widely-known consensus outlook gives a good sense of the company's earnings picture, but how the actual results compare to these estimates is a powerful factor that could impact its near-term stock price.The earnings report might help the stock move higher if these key numbers are better than expectations. On the other hand, if they miss, the stock may move lower.While management's discussion of business conditions on the earnings call will mostly determine the sustainability of the immediate price change and future earnings expectations, it's worth having a handicapping insight into the odds of a positive EPS surprise.This specialty drugmaker is expected to post quarterly earnings of $0.57 per share in its upcoming report, which represents a year-over-year change of -8.1%.Please note that a negative Earnings ESP reading is not indicative","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/analysts-estimate-pacira-pcrx-report-140130168.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["PCRX","MRNA"],"gpt_icon":0},{"id":"2531733665","title":"Pacira to Report First Quarter 2025 Financial Results on Thursday May 8, 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2531733665","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531733665?lang=en_us&edition=fundamental","pubTime":"2025-04-29 20:00","pubTimestamp":1745928000,"startTime":"0","endTime":"0","summary":"Pacira delivers innovative, non-opioid pain therapies to transform the lives of patients. Pacira has three commercial-stage non-opioid treatments: EXPAREL , a long-acting local analgesic currently approved for infiltration, fascial plane block, and as an interscalene brachial plexus nerve block, an adductor canal nerve block, and a sciatic nerve block in the popliteal fossa for postsurgical pain management; ZILRETTA , an extended-release, intra-articular injection indicated for the management of osteoarthritis knee pain; and iovera, a novel, handheld device for delivering immediate, long-acting, drug-free pain control using precise, controlled doses of cold temperature to a targeted nerve. The company is also advancing the development of PCRX-201 , a novel locally administered gene therapy with the potential to treat large prevalent diseases like osteoarthritis. To learn more about Pacira, visit www.pacira.com.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/pacira-report-first-quarter-2025-120000423.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["PCRX","BK4007"],"gpt_icon":0},{"id":"2530314362","title":"Pacira BioSciences' Gene Therapy Shows Long-Term Improvement in Knee Osteoarthritis Symptoms","url":"https://stock-news.laohu8.com/highlight/detail?id=2530314362","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530314362?lang=en_us&edition=fundamental","pubTime":"2025-04-28 23:51","pubTimestamp":1745855504,"startTime":"0","endTime":"0","summary":"Pacira BioSciences (PCRX) said Monday that two-year results from a Phase 1 study showed its gene therapy candidate PCRX-201 provided sustained improvements in pain, stiffness, and function in patients","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4007","PCRX"],"gpt_icon":0},{"id":"2530401340","title":"Pacira BioSciences Announces Two-Year Efficacy Data Following a Single Local Administration of PCRX-201 in Patients with Mild to Severe Osteoarthritis of the Knee","url":"https://stock-news.laohu8.com/highlight/detail?id=2530401340","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530401340?lang=en_us&edition=fundamental","pubTime":"2025-04-28 20:00","pubTimestamp":1745841600,"startTime":"0","endTime":"0","summary":"-- PCRX-201 demonstrated two years of clinically meaningful improvements in pain, stiffness and function across all structural severity subgroups, including advanced disease --. -- Study Findings Presented at 2025 OARSI World Congress--. BRISBANE, Calif., April 28, 2025  -- Pacira BioSciences, Inc. , the industry leader in its commitment to deliver innovative, non-opioid pain therapies to transform the lives of patients, today announced new data demonstrating its locally administered gene therapy candidate, PCRX-201 , provided sustained improvements in knee pain, stiffness, and function for up to two years following a single local administration in patients with mild, moderate, as well as severe osteoarthritis of the knee. The data was presented during a poster session at the 2025 Osteoarthritis Research Society International  World Congress in Incheon, South Korea, on Friday, April 25, and Saturday, April 26.The open-label, phase 1 trial investigated the efficacy of PCRX-201 administe","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/pacira-biosciences-announces-two-efficacy-120000555.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4007","ATMP","PCRX"],"gpt_icon":0},{"id":"2529557038","title":"Pacira BioSciences to Present 104-Week Efficacy Data Following a Single Local Administration of PCRX-201 for Patients with Mild to Severe Osteoarthritis of the Knee","url":"https://stock-news.laohu8.com/highlight/detail?id=2529557038","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529557038?lang=en_us&edition=fundamental","pubTime":"2025-04-23 04:01","pubTimestamp":1745352060,"startTime":"0","endTime":"0","summary":"-- Poster to be presented at OARSI World Congress on Osteoarthritis --. BRISBANE, Calif., April 22, 2025  -- Pacira BioSciences, Inc. , the industry leader in its commitment to deliver innovative, non-opioid pain therapies to transform the lives of patients, today announced the upcoming presentation of new 104-week data in support of its locally administered gene therapy candidate, PCRX-201 . The data is being presented at the 2025 Osteoarthritis Research Society International  World Congress in Incheon, South Korea, April 24-27.Presentation Title: Improvements in Pain, Stiffness, and Function After a Single Intraarticular Injection of Gene Therapy PCRX-201 for Knee Arthritis Osteoarthritis: A Subgroup Analysis by Structural Severity. Presented By: Ali Mobasheri, Professor of Musculoskeletal Biology at the University of Oulu in Oulu, Finland; Chief Researcher and International Adviser in the State Research Institute Centre for Innovative Medicine in Vilnius, Lithuania. PCRX-201  featur","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/pacira-biosciences-present-104-week-200100290.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["PCRX","BK4007","ATMP"],"gpt_icon":0},{"id":"2529803224","title":"BRIEF-DOMA Perpetual Supports Pacira's New $300 Million Share Repurchase Authorization As A Meaningful Step To Enhance Value For Shareholders","url":"https://stock-news.laohu8.com/highlight/detail?id=2529803224","media":"Reuters","labels":["shareholding","buyback","event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529803224?lang=en_us&edition=fundamental","pubTime":"2025-04-21 20:17","pubTimestamp":1745237846,"startTime":"0","endTime":"0","summary":"BRIEF-DOMA Perpetual Supports Pacira's New $300 Million Share Repurchase Authorization As A Meaningful Step To Enhance Value For ShareholdersApril 21 (Reuters) - Pacira Biosciences Inc PCRX.O:DOMA PER","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250421:nTUA9G720:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,buyback,event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","PCRX"],"gpt_icon":0},{"id":"2529805380","title":"DOMA Perpetual Supports Pacira's New $300 Million Share Repurchase Authorization as a Meaningful Step to Enhance Value for Shareholders","url":"https://stock-news.laohu8.com/highlight/detail?id=2529805380","media":"PR Newswire","labels":["shareholding","buyback"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529805380?lang=en_us&edition=fundamental","pubTime":"2025-04-21 20:15","pubTimestamp":1745237700,"startTime":"0","endTime":"0","summary":"DOMA Perpetual Believes Pacira's Stock Is Undervalued, Presenting an Opportunity to Execute the Largest Buyback in the Company's History. MIAMI, April 21, 2025 /PRNewswire/ -- DOMA Perpetual Capital Management LLC  is a fundamentals-based, value-oriented asset management firm which beneficially owns approximately 4.2% of the outstanding shares of common stock of Pacira BioSciences, Inc.  .Following constructive engagement with Pacira, DOMA Perpetual believes the Company's new capital allocation announcementi represents the Board's firm commitment to enhancing shareholder value.For the avoidance of doubt, this press release was not produced by any person that is affiliated with Pacira, nor was its content endorsed by Pacira. This press release is provided merely as information and is not intended to be, nor should it be construed as, an offer to sell or a solicitation of an offer to buy any security nor as a recommendation to","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/doma-perpetual-supports-paciras-300-121500412.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/doma-perpetual-supports-paciras-300-121500412.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,buyback","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4007","PCRX","DOMA","BK4079"],"gpt_icon":0},{"id":"2528771932","title":"Pacira BioSciences Approves $300 Million Share Repurchase Program","url":"https://stock-news.laohu8.com/highlight/detail?id=2528771932","media":"MT Newswires Live","labels":["shareholding","buyback"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2528771932?lang=en_us&edition=fundamental","pubTime":"2025-04-18 05:36","pubTimestamp":1744925781,"startTime":"0","endTime":"0","summary":"Pacira Biosciences  said Thursday its board approved a $300 million share repurchase program.The program replaces the previous authorization announced on May 7, 2024, and has the same terms, according to the company.The share repurchase authorization expires at the end of December 2026, Pacira added.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,buyback","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4007","PCRX"],"gpt_icon":0},{"id":"2528577903","title":"BRIEF-Pacira Biosciences Inc - Authorizes $300 Million Share Repurchase Program","url":"https://stock-news.laohu8.com/highlight/detail?id=2528577903","media":"Reuters","labels":["shareholding","buyback"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2528577903?lang=en_us&edition=fundamental","pubTime":"2025-04-18 05:25","pubTimestamp":1744925139,"startTime":"0","endTime":"0","summary":"BRIEF-Pacira Biosciences Inc - Authorizes $300 Million Share Repurchase ProgramApril 17 (Reuters) - Pacira Biosciences Inc PCRX.O:PACIRA BIOSCIENCES INC - AUTHORIZES $300 MILLION SHARE REPURCHASE PROG","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250417:nFWN3QV3EI:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,buyback","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PCRX","BK4007"],"gpt_icon":0},{"id":"2528790127","title":"Pacira Biosciences Approves $300M Share Buyback","url":"https://stock-news.laohu8.com/highlight/detail?id=2528790127","media":"Dow Jones","labels":["shareholding","buyback"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2528790127?lang=en_us&edition=fundamental","pubTime":"2025-04-18 05:24","pubTimestamp":1744925040,"startTime":"0","endTime":"0","summary":"Pacira Biosciences has authorized a share buyback program of up to $300 million.The developer of non-opioid pain relievers said Thursday the repurchase program replaces a previous $150 million buyback plan authorized in May 2024.The new plan expires at the end of December 2026, Pacira said.\"This increased share repurchase authorization underscores the board's confidence in Pacira's growth strategy and our commitment to delivering value to shareholders,\" Chief Executive Frank Lee said.","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,buyback","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","PCRX"],"gpt_icon":0}],"pageSize":20,"totalPage":7,"pageCount":3,"totalSize":124,"code":"91000000","status":"200"}]}}